4
Changes in Ownership
Viridian Therapeutics, Inc.\DE Filed Acc 0000899243-22-016657
Chief Executive Officer sold 30,000 shares at $13.04 ($391,200)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Violin Jonathan Chief Executive Officer | 2022-05-02 | Sale | −30,000 | $13.04 | $391,200 | 510,905 | D |
| Open-market sales · 30,000 sh · avg $13.04 · $391,200 | |||||||
Loading xslF345X03/doc4.xml…